Introduction
Increased G 2 chromosomal radiosensitivity of peripheral blood lymphocytes has been associated with a number of common sporadic cancers including breast (1) (2) (3) (4) (5) (6) (7) (8) (9) , colorectal (5), prostrate (10) , head and neck (11, 12) and a range of early-onset cancers (13) and heritability of the radiosensitive phenotype has been demonstrated (4, (14) (15) (16) (17) . These observations suggest that G 2 chromosomal radiosensitivity may be a marker of inherited low penetrance cancer predisposition genes (3, 5, 8, 18, 19) . The G 2 radiosensitivity assay involves irradiating peripheral blood lymphocytes in vitro during the G 2 phase of the cell cycle with a low dose of radiation to induce DNA damage. Cells are then allowed to progress to metaphase, at which point damage can be quantified by counting the number of chromatid gaps and breaks observed. The assay is recognised as technically demanding and requires stringent laboratory conditions and scoring techniques (20) . The assay was originally developed by Sanford et al. (21) and later modified and refined by Scott et al. (2) to minimise problems with reproducibility of aberration yields. However, since most laboratories adopt minor modifications to the experimental protocol, direct comparison of study results is rarely possible. Although many laboratories using the technique have reported highly reproducible results (5, 14, 22) , others have found that some individuals exhibit significant variability when repeatedly sampled (8, 13, (23) (24) (25) . Here, we examine the results from repeatedly sampling two individuals over an extended period of time and discuss the possible reasons for the intraindividual variability observed. Samples were taken as part of ongoing studies (15, 17, 24) to act as assay controls and thus were always coded to ensure anonymity. Approval for the different studies was obtained from the West Cumberland Local Research Ethics Committee and/or the Danish Scientific Ethical Committee and the Danish Data Protection Agency. Informed consent was also provided by the individuals. Donor 1 provided 13 samples (Time Period 1) for a validation study to establish the G 2 assay technique (24) . Subsequently, Donor 1 provided a set of six samples (Time Period 2) as the internal assay control in a study of G 2 chromosomal radiosensitivity in childhood and young adult cancer survivors (15) , two further samples (Time Period 3) and seven samples (Time Period 4) for the follow on study of G 2 chromosomal radiosensitivity in childhood and young adult cancer survivors (17) . Donor 2 was a transport control for the two studies of G 2 chromosomal radiosensitivity in childhood and young adult cancer survivors, providing nine (Period 2) and seven (Period 4) samples which were sent from Denmark in conjunction with the cancer family samples (15, 17) . In total, Donor 1 provided 28 samples and Donor 2 provided 16 samples. In all instances, blood was cultured at the Westlakes Research Institute (WRI) laboratory within 24 h of being drawn. Here we present, for the first time, the analysis of the complete data sets for the two donors.
Materials and methods

Blood samples
The G 2 assay The G 2 chromosomal radiosensitivity assay was performed according to the method previously described (15, 24) . Peripheral blood was drawn into lithium heparin vacutainers (Fisher Scientific, Leicestershire, UK) and cultures (2 ml blood) were set up in pre-warmed (37°C) and pre-gassed (5% CO 2 /95% air) Roswell Park Memorial Institute (RPMI-1640) medium (Sigma-Aldrich, Dorset, UK) supplemented with 15% foetal calf serum (Invitrogen Limited, Paisley, UK), 1% L-glutamine (Invitrogen Limited) and 1% phytohaemagglutinin (M-form) (Invitrogen Limited) to a total volume of 20 ml. Each culture was set up in either triplicate (15) or duplicate (17, 24) , resulting in either one or two flasks (VWR International, Leicestershire, UK) to be irradiated for the determination of the induced aberration frequency and one flask for the determination of the spontaneous aberration frequency. A single foetal calf serum batch was used for the entire period of each particular study. Flasks were placed upright in a humidified, CO 2 -gassed incubator (Binder, Tuttlingen, Germany). After 48 h, 15 ml of medium was carefully removed and replaced with 15 ml of fresh pre-gassed, pre-warmed medium. At 72 h, the cells were transported in Lymphocytes were cultured for 72 h prior to irradiation with 0.5 Gy, 300 kV Xrays. Colcemid was added 30 min post-irradiation. Cultures were harvested 90 min post-irradiation and analysed for chromatid gaps and breaks. Donor 1 exhibited significant intra-individual variation in G 2 chromosomal radiosensitivity for two of the four time periods. Variation was not significant for Period 1 (13 samples, P 5 0.111) and Period 2 (six samples, P 5 0.311) but was significant for Period 3 (two samples, P 5 0.030) and Period 4 (seven samples, P 5 0.005). Significant intra-individual variation was observed for both time periods involving Donor 2, these being Period 2 (nine samples, P 5 0.002) and Period 4 (seven samples, P < 0.001).
The combined data from all time periods exhibited a significant intra-individual variation for Donor 1 (P < 0.001) and Donor 2 (P < 0.001). These findings led to the conclusion that too much reliance should not be placed on the result from a single sample when assessing individual radiosensitivity status.
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Materials and methods
Blood samples
The G 2 assay The G 2 chromosomal radiosensitivity assay was performed according to the method previously described (15, 24) . Peripheral blood was drawn into lithium heparin vacutainers (Fisher Scientific, Leicestershire, UK) and cultures (2 ml blood) were set up in pre-warmed (37°C) and pre-gassed (5% CO 2 /95% air) Roswell Park Memorial Institute (RPMI-1640) medium (Sigma-Aldrich, Dorset, UK) supplemented with 15% foetal calf serum (Invitrogen Limited, Paisley, UK), 1% L-glutamine (Invitrogen Limited) and 1% phytohaemagglutinin (M-form) (Invitrogen Limited) to a total volume of 20 ml. Each culture was set up in either triplicate (15) or duplicate (17, 24) , resulting in either one or two flasks (VWR International, Leicestershire, UK) to be irradiated for the determination of the induced aberration frequency and one flask for the determination of the spontaneous aberration frequency. A single foetal calf serum batch was used for the entire period of each particular study. Flasks were placed upright in a humidified, CO 2 -gassed incubator (Binder, Tuttlingen, Germany). After 48 h, 15 ml of medium was carefully removed and replaced with 15 ml of fresh pre-gassed, pre-warmed medium. At 72 h, the cells were transported in Metaphase slides were made according to standard procedures and stained with Giemsa (VWR International). For each irradiated sample, 100 well-spread metaphases were analysed and the total number of chromatid gaps and breaks determined to give a G 2 aberration frequency. Chromatid-type aberrations were scored according to previously outlined criteria (24) , with breaks being defined as mis-aligned discontinuities and gaps as single aligned discontinuities wider than the width of a chromatid. Two scorers were used to score each sample to eliminate scorer bias, with each scorer analysing 50 metaphases per sample. One scorer was used for all four time periods and, whilst the second scorer remained the same for Periods 1-3, a different scorer was used in Time Period 4. Scoring criteria were periodically checked to ensure that there were no differences between scorers. Earlier studies using the G 2 assay in our laboratory (15, 24) indicated that the spontaneous aberration yield was negligible (,1.0 aberration per 100 cells) and therefore, no adjustment for spontaneous yield was made in the analysis of the results for the present study.
Statistical methods
The distributions of chromatid aberrations among metaphase cells in all samples from each individual were analysed for approximation to the Poisson distribution as previously described (24) . If the observed distributions follow Poisson statistics, the variance and the mean of the observed distributions would be equal and a ratio value of 1.0 would be expected. If the variance is greater than the mean, aberrations are overdispersed and the Poisson distribution does not apply. Ratios of variance to mean (the mean being the number of aberrations divided by the number of metaphase cells studied) were calculated for each sample and an average value for each donor (Z) determined for each of the four time periods, as well as a combined study value for each individual ( Table I) .
Homogeneity of repeat sampling was investigated using chi squared (v 2 ) with the Poisson derived variance (the expected value) adjusted to account for the observed overdispersion of aberrations and thus, the formula v 2 5 P (OÀ E) 2 /(EZ) was adopted, where O is the observed value of aberrations per 100 cells, E is the expected value of aberrations per 100 cells and Z is the compensation factor defined above.
Standard errors for mean aberration yields were calculated by adjusting for overdispersion and any additional intra-individual variation according to the formula O(number of aberrations Â Z Â Y), and then normalising to 100 cells scored. Y was estimated by summing all the chi-squared values and dividing by the total degrees of freedom.
Results
Chromatid aberration frequencies for each sample time period from each donor are presented in Figure 1 . Mean induced aberration frequencies and coefficients of variation (CVs) for and 16%, respectively) was not significantly different from the inter-individual variability observed for the group as a whole (CV 5 17%) and the authors concluded that the assay was unlikely to detect any real differences in radiation sensitivity that exist between normal individuals. In an extension of the 2002 study, Vral et al. (25) observed no significant intra-individual variation in three of four repeatedly sampled individuals. However, the intra-individual variances obtained (22, 17, 14 and 21%, respectively) were not significantly different from the inter-individual variance calculated for 57 individuals (20%) in the same study. Despite the high intra-individual variability shown by some individuals, the authors conclude that G 2 chromosomal radiosensitivity assay is able to examine effectively population radiosensitivity and the relationship between radiosensitivity, cancer predisposition and genotype. In the WRI laboratory, intra-individual variation was found to be statistically significant in two of nine donors who provided repeat samples (CV 5 30.6 and 20.2%, respectively) (24). In both individuals, variability was driven by one particularly high result of a total of three and five samples respectively, removal of which resulted in intra-individual variations that were not statistically significant. Three of four donors repeatedly sampled by Howe et al. (8) demonstrated CVs between 4.6 and 5.1%, but a fourth donor had a CV of 22.9%. It was concluded that the high intra-individual variation seen in this donor might be an intrinsic factor within the individual.
High standards of intrinsic assay reproducibility have previously been demonstrated in a validation study undertaken by the WRI laboratory (24) . It therefore seems unlikely that experimental error contributed significantly to the intra-individual variability in G 2 chromosomal radiosensitivity observed in the present study and other possible explanations must be sought.
Genetic variation in the ability to maintain genomic integrity is likely influenced by a range of factors, including diet and immune status. These factors may change, and repeated blood samples from an individual may therefore differ in serum composition and cell profile and hence the response to radiation (23) . Changes in hormone levels have been shown to have a profound effect upon radiosensitivity. Blood samples taken during pregnancy from mice (26) and humans (27) have demonstrated increased chromosomal radiosensitivity in comparison with blood samples from non-pregnant females. This increase in radiosensitivity was thought to be associated with pregnancy hormones, particularly progesterone. Support for this view came from a subsequent in vitro study in which progesterone added to irradiated cultures resulted in an increased frequency of radiation-induced chromosomal rearrangements (28) (31) reported no correlation between in vivo fluctuations in estradiol and progesterone concentrations in healthy women and in vitro radiation-induced micronucleus frequencies, nor was there any association between the concentrations of hormones added in vitro to lymphocyte cultures prior to radiation and aberration yield. Support for a possible hormonal influence on chromosomal radiosensitivity could be drawn from the present study. Donor 2 became pregnant during sampling for Time Period 2 and examination of the samples provided pre-pregnancy and during pregnancy revealed no intra-individual variation in the samples taken before (v Examination of the whole study period of 5.75 years reveals that Donor 1 had time periods when she did not exhibit significant variation, i.e. Periods 1 and 2. However, for Time Periods 3 and 4, the intra-individual variation in response to G 2 radiation was significant. Donor 2 provided samples for Periods 2 and 4 over 4.75 years and exhibited significant variation in G 2 chromosomal radiosensitivity in both studies. The greatest range of values for both donors was observed in the last time period between June and December 2006, these being 85-150 aberrations per 100 cells for Donor 1 and 75-187 aberrations per 100 cells for Donor 2 (Table I) . Samples taken during this 6-month period showed statistically significant intra-individual variation for both donors. By this time, both donors were 41 years of age and may well have been undergoing greater hormonal fluctuations than at earlier sampling periods. If hormonal status can influence chromosomal radiosensitivity, this may explain the greater intra-individual variation observed at the later sampling time.
In addition to the observed intra-individual variation, Figure 1 suggests an increase in aberration yields with increasing sampling time and, apart from the two samples in study Period 3 for Donor 1, the mean values increase with increasing time periods (Table I) . A measure of the influence of increasing sampling time was obtained by linear regression analysis of aberration frequency on days since first sample, which provided R 2 values of 21.8% for Donor 1 and 30.2% for Donor 2. Some of the variation can therefore be explained, but whether this is indicative of an increase in G 2 chromosomal radiosensitivity with age requires further investigation particularly as other studies have failed to find such an effect (3,5,13).
Previous studies have reported that the G 2 assay requires stringent technical conditions to produce reproducible chromatid aberration yields, with problems possibly associated with blood sample storage and transport conditions, in particular, transit over long distances (2, 20) . However, others and indeed our own laboratory have demonstrated blood storage conditions to have no effect on aberration yield (2, 3, 24) . In addition, transportation over short distances has been suggested to have no effect on reproducibility (6, 14, 24) . In the current study, samples from Donor 1 were drawn both on-site at WRI or at the West Cumberland Hospital some 2 km from WRI. Samples from Donor 2 were sent to WRI from Denmark but, in order to avoid significant temperature fluctuations, these samples were sent in secondary packaging and in the possession of a personal courier at all times. Although a transportation effect cannot be entirely ruled out as contributing to the intra-individual variability observed for Donor 2, this seems unlikely since there was no correlation between the values for chromosomal radiosensitivity found for Donor 2 and those for the samples from cancer families, in particular the partner controls, that were sent at the same time (data not provided). Possible influences associated with specific culture conditions can also be ruled out since there is no common pattern of high and low aberration yields for the two donors (Figure 1) .
Many studies investigating G 2 chromosomal radiosensitivity use the 90th percentile cut-off point of the healthy control population to define heightened sensitivity when making comparisons with the radiosensitive profiles of populations with specific clinical conditions e.g. cancer [see ref. (17) for review]. We have previously reported the radiosensitivity profile of samples taken from 27 healthy apparently normal individuals at WRI taken during Time Periods 1 and 2 (15) and, using the revised scoring criteria (outlined in Materials and methods above), can derive a 90th percentile cut-off point of 122.6 aberrations per 100 cells. Examination of the results from Donor 1, who was sampled at WRI, for the combined Time Periods of 1 and 2 indicate that while 18 of the 19 samples provided aberration scores below this value, the final sample gave a marginally higher value of 128.0 aberrations per 100 cells. During Time Periods 2 and 4, samples were also taken and transported from Denmark from the partners of childhood cancer survivors to provide radiosensitivity profiles of control healthy populations for comparison with the cancer survivors and their offspring (15, 17) . The 90th percentile cut-off points defining the radiosensitive phenotype were 162.4 and 167.8 aberrations per 100 cells, respectively (using the scoring criteria outlined in Materials and methods above). The repeated sampling of Donors 1 and 2 during these time periods revealed no aberration yields higher than the 90th percentile cut-off point for the cancer partner control population for either donor in Time Period 2 but the final sample for Donor 2 in Time Period 4 exceeded the cut-off point, with a value of 187.0 aberrations per 100 cells and on this sample alone, she would have been classed as radiosensitive.
Although the G 2 chromosomal radiosensitivity assay has been shown to distinguish differences in sensitivity profiles between different populations, the variation observed in some people when repeatedly sampled suggests that too much reliance should not be placed on any one result when considering the radiosensitive status of a particular individual. Family studies have shown that the G 2 chromosomal radiosensitivity phenotype has a strong heritable component (4, 15, 17, 29) but it seems likely that, at least in some individuals, this may be modified by other, as yet, ill-defined factors. 
